Role of microglia in multiple sclerosis

Current Neurology and Neuroscience Reports

Volumn 5, Issue 3, 2005, Pages 239-244

  Deng, Xinqing ^b   Sriram, Subramanian ^a  

^a Vanderbilt Stallworth Rehabilitation Hospital   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 3; MYELIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTATION; AUTOIMMUNITY; CELL DEATH; CELL FUNCTION; CELL PROTECTION; CYTOKINE RELEASE; DEMYELINATION; DISEASE ACTIVITY; ENCEPHALOMYELITIS; GENE OVEREXPRESSION; HUMAN; MACROPHAGE; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL; NERVOUS SYSTEM; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; PATHOPHYSIOLOGY; REVIEW; T LYMPHOCYTE;

EID: 21044450071     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-005-0052-x     Document Type: Review

References (47)

1. Streit WJ, Kincaid-Colton A: The brains's immune system. Sci Am 1995, 83:54-60.
2. Neumann H, Cavalie A, Jenne DE, Wekerle H: Induction of MHC class I genes in neurons. Science 1995, 269:549-552.
3. Streit WJ: Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 2002, 40:133-139.
4. Nakamura Y: Regulating factors fro microglial activation. Biol Pharm Bull 2002, 25:945-953.
5. Aloisi F: Immune function of microglia. Glia 2001, 36:165-179.
6. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG: Multiple sclerosis. N Engl J Med 2000, 343:938-952.
7. McDonald WI, Compston A, Edan G, et al.: Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50:121-127.
8. Lumsden CE: The immunogenesis of the MS plaque. Brain Res 1971, 28:365-371.
9. Carson MJ: Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis. Glia 2002, 40:218-231.
10. Benveniste EN: Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J Mol Med 1997, 75:165-173.
11. Perry VH, Gordon S: Macrophages and the nervous system. Int Rev Cytol 1991, 125:203-244.
12. Rio-Hortega D: Microglia, vol 2. Edited by Penfield W. New York: Paul B. Hoecker; 1932.
13. Hickey W, Kimura H: Perivascular microglial cells of the CNS are bone marrow derived and present antigen in vivo. Science 1988, 239:290-293.
14. Cuadros MA, Navascues J: The origin and differentiation of microglial cells during development. Prog Neurobiol 1998, 56:173-189.
15. Ling EA: The ontogeny of microglial cells. Adv Cell Neurobiol 1981, 2:32-82.
16. Guillemin GJ, Brew BJ: Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukocyte Biol 2004, 75:388-397.
17. Rock RB, Gekker G, Hu S, et al.: Role of microglia in central nervous system infections. Clin Microbiol Rev 2004, 17:942-964.
18. Nelson PT, Soma LA, Lavi E: Microglia in diseases of the central nervous system. Ann Med 2002, 34:491-500.
19. Ulvestad E, Williams K, Bjerkvig R, et al.: Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen-presenting cells. J Leukocyte Biol 1994, 56:732-740.
20. Nguyen MD, Julien JP, Rivest S: Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat Rev Neurosci 2002, 3:216-227.
21. Toft-Hansen H, Nuttall RK, Edwards DR, Owens T: Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis. J Immunol 2004, 173:5209-5218.
22. John GR, Lee SC, Brosnan CF: Cytokines; powerful regulators of glial cell activation. Neuroscientist 2003, 9:10-22.
23. Raine CS: Multiple sclerosis: immunopathological mechanisms in the progression and resolution of inflammatory demyelination. Res Publ Assoc Res Nerv Ment Dis 1990, 68:37-54.
24. Lucchinetti C, Bruck W, Parisi J, et al.: Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000, 47:707-717.
25. Prineas JW: Pathlogy of multiple sclerosis. In Handbook of Multiple Sclerosis. Edited by Cook S. New York: Marcel Dekker; 1990:187-215.
26. Hartung HP, Grossman RI: ADEM: distinct disease or part of the MS spectrum? Neurology 2001, 56:1257-1260.
27. Dale RC: Acute disseminated encephalomyelitis. Semin Pediatr Infect Dis 2003, 14:90-95.
28. Martin R, McFarland HF, McFarlin DE: Immunology of demyelinating disease. Ann Rev Immunol 1992, 10:153-169.
29. Mcfarlin DE, Mcfarland HF: Multiple Sclerosis. N Engl J Med 1982, 307:1183-1188.
30. Zamvil SS, Steinman LS: The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 1990, 8:579-621.
31. Genain CP, Nguyen MH, Letvin NL, et al.: Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J Clin Invest 1995, 96:2966-2974.
32. Linington C, Berger T, Perry L, et al.: T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol 1993, 23:1364-1372.
33. Iglesias A, Bauer J, Litzenburger T, et al.: T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 2001, 36:220-234.
34. Chiang CS, Powell HC, Gold LH, et al.: Macrophage/microglial mediated primary demyelination and motor disease induced by the CNS production of IL-3 in transgenic mice. J Clin Invest 1996, 97:1512-1524.
35. Owens T, Wekerle H, Antel J: Genetic models of CNS inflammation. Nat Med 2001, 7:161-166.
36. Owens T: The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage. Curr Opin Neurol 2003, 16:259-265.
37. Selmaj KW, Raine CS: TNF alpha myelin and oligodendrocyte injury in vitro. Ann Neurol 1989, 23:339-345.
38. Sriram S, Rodriguez M: Indictment of the microglia as the villain in multiple sclerosis. Neurology 1997, 48:464-470.
39. Olson JK, Miller SD: Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 2004, 173:3916-3924.
40. Rivest S: Molecular insights on the cerebral innate immune system. Brain Behav Immunol 2003, 17:13-19.
41. Budka H: Neuropathology of human immunodeficiency virus infection. Brain Pathol 1991, 1:163-175.
42. Barnett MH, Prineas TW: Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 2004, 55:458-468.
43. McGeer PL, Kawamata T, Walker DG, et al.: Microglia in degenerative neurological disease. Glia 1993, 7:84-92.
44. Henson PM, Bratton DL, Fadok VA: The phosphatidylserine receptor: a crucial molecular switch? Nat Rev Mol Cell Biol 2001, 2:627-633.
45. Fadok VA, Bratton DL, Henson PM: Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J Clin Invest 2001, 108:957-962.
46. Bo L, Vedeler CA, Nyland HI, et al.: Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003, 62:723-732.
47. Bo L, Vedeler CA, Nyland H, et al.: Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 2003, 9:323-331.